Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 0 | 0 | 3,500 |
| Cost of Goods | N/A | N/A | 30 | N/A | 1,575 |
| Gross Profit | N/A | N/A | -30 | N/A | 1,925 |
| Operating Expenses | 17,864 | 14,330 | 13,209 | 11,334 | 13,054 |
| Operating Income | -17,864 | -14,330 | -13,209 | -11,334 | -10,554 |
| Interest Expense | 1,072 | 952 | 109 | 105 | 103 |
| Other Income | 26,342 | -16,296 | -3,273 | -397 | -5,997 |
| Pre-tax Income | 7,406 | -31,578 | -16,591 | -11,836 | -16,654 |
| Net Income Continuous | 7,406 | -31,578 | -16,591 | -11,836 | -16,654 |
| Net Income | $7,406 | $-31,578 | $-16,591 | $-11,836 | $-16,654 |
| EPS Basic Total Ops | 0.19 | -1.16 | -0.59 | -0.48 | -0.92 |
| EPS Basic Continuous Ops | 0.19 | -1.16 | -0.59 | -0.48 | -0.92 |
| EPS Diluted Total Ops | -0.26 | -1.16 | -0.59 | -0.48 | -0.92 |
| EPS Diluted Continuous Ops | 0.14 | -1.16 | -0.59 | -0.48 | -0.92 |
| EPS Diluted Before Non-Recurring Items | -0.75 | -0.53 | -0.64 | -0.48 | -0.44 |
| EBITDA(a) | $-17,179 | $-13,606 | $-12,488 | $-10,583 | $-9,716 |